Evotec partner HAPLOGEN enters into collaboration with Bayer
Evotec announced that Haplogen, a Vienna-based biotechnology company and collaboration partner of Evotec, has entered into a multi-year drug discovery and development collaboration with Bayer to identify new therapeutics with applications in pulmonary diseases such as COPD. August 14, 2018